Biocon 报告称，2023 年第三季度的综合净利润为 66 亿卢比，高于 2022 年第三季度的 4.2 亿卢比亏损。 Biocon reports consolidated net profit of Rs 660 crore in Q3 2023, up from Rs 42 crore loss in Q3 2022.
生物技术公司 Biocon 报告，截至 2023 年 12 月 31 日的第三季度综合净利润为 66 亿卢比。 Biocon, a biotech firm, reported a consolidated net profit of Rs 660 crore in the third quarter ended on December 31, 2023. 这标志着上一财年同期净亏损 4.2 亿卢比的显着改善。 This marked a significant improvement from the net loss of Rs 42 crore during the same period in the previous fiscal year. 这一时期的总收入增至 451.9 亿卢比，而上年同期为 302 亿卢比。 Total revenue during this period increased to Rs 4,519 crore as compared to Rs 3,020 crore in the same period of the previous year.